Delivery Order SPE2DB20D1100-SPE2DB25FC9J9
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,255.74 for Carvedilol ER 20 mg capsules (30-count) with an ultimate completion date of August 28, 2025. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $2,537.02 to AmerisourceBergen Drug Corp for Carvedilol ER 20 mg capsules (30-count units) on June 16, 2025, with completion scheduled for June 17, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award based on capability demonstration. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains...
- The Defense Logistics Agency awarded a delivery order valued at $14,634.92 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count units) on December 8, 2025, with an ultimate completion date of December 9, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $5,210.71 to AmerisourceBergen Drug Corp on August 23, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units). This is a firm fixed-price delivery order with a completion deadline of August 25, 2025, and represents a non-set-aside competitive procurement. The award will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count units) valued at $3,734.34. This is a firm fixed-price delivery order with an ultimate completion date of December 3, 2025, and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The award was made through open competition with no set-aside designation. AmerisourceBergen, a major...
- The Defense Logistics Agency awarded a $1,353.29 delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 40 mg capsules (30-count) on August 21, 2025, with completion expected by August 22, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a single pharmaceutical supply transaction executed under AmerisourceBergen's larger federal contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $18,627.47 by the Defense Logistics Agency for the supply of Carvedilol ER 20 mg capsules (30-count units), with an ultimate completion date of June 3, 2025. This is a firm fixed-price, non-set-aside contract with performance conducted at the vendor's Conshohocken, Pennsylvania location. The delivery order was competitively awarded on June 2, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 20 mg capsules (30-count units) under a firm fixed-price contract valued at $15,959.88. The award, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded a $1,872.12 delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 20 mg capsules (30-count units) on September 2, 2025, with a completion date of September 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a $9,508.89 delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 80 mg capsules (30-count) on October 22, 2025, with an ultimate completion date of October 23, 2025. This competitive award, using firm fixed pricing, represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be performed...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FC9J9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,104.35 to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count). This firm fixed price delivery order, with an ultimate completion date of June 18, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this procurement. The award falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which provides comprehensive global pharmaceutical support to military healthcare programs. As a major pharmaceutical distributor and critical federal medical supply vendor, AmerisourceBergen Drug Corp fulfills a significant role in supporting military and veteran healthcare systems. The Carvedilol ER delivery order exemplifies the company's routine provision of generic and brand-name medications across multiple therapeutic domains through the DLA's medical supply chain. The underlying IDC vehicle enables flexible procurement of pharmaceutical products and medical supplies to support Defense Health Agency operations and other government healthcare systems worldwide, with DLA Troop Support planning to establish additional Pharmaceutical Prime Vendor Global Program Generation V regional contracts involving multiple contractors in the future.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 6/17/25 |